Skip to content

Clinical trials

Completed Phase 1/2 Hodgkin Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Phase 1/2 Status: Completed Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20022
20037
20043
20055
20062
20076
20087
20095
20105
20113
20127
20133
20145
20155
20162
20172
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center9
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center5
University of Washington4
Mayo Clinic3
Memorial Sloan Kettering Cancer Center3
Seagen Inc.3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Bristol-Myers Squibb2
Columbia University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease89
Lymphoma, Non-Hodgkin52
Lymphoma37
Leukemia, Lymphocytic, Chronic, B-Cell34
Precursor Cell Lymphoblastic Leukemia-Lymphoma31
Multiple Myeloma30
Lymphoma, Large B-Cell, Diffuse29
Lymphoma, Follicular27
Lymphoma, Mantle-Cell27
Leukemia, Myeloid, Acute24

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.